Back
Milestone Pharmaceuticals Vs. Monopar Therapeutics Industry Stock Comparison
Sell
47
MIST
Milestone Pharmaceuticals
Last Price:
$2.19
Seasonality Move:
-19.56%
Buy
72
MNPR
Monopar Therapeutics
Last Price:
$46.13
Seasonality Move:
-10.68%
Sell
47
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $2.19. The Score for MIST is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $47.11. The Score for MNPR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $2.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $47.11Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight selling pressure.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 61.95 | Buy |
Chaikin Money Flow: | 804129 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.96 - 2.18) | Buy |
Bollinger Bands (100): | (1.52 - 2.02) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.91 | Buy |
Relative Strength Index (14 RSI): | 67.54 | Buy |
Chaikin Money Flow: | -4578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.48 - 42.44) | Buy |
Bollinger Bands (100): | (7.67 - 31.27) | Buy |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.02 | Buy |
20-day SMA: | 2.03 | Buy |
50-day SMA: | 1.97 | Buy |
200-day SMA: | 1.64 | Buy |
8-day EMA: | 2.05 | Buy |
20-day EMA: | 2.03 | Buy |
50-day EMA: | 1.96 | Buy |
200-day EMA: | 1.83 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.31 | Buy |
20-day SMA: | 36.03 | Buy |
50-day SMA: | 28.53 | Buy |
200-day SMA: | 11.37 | Buy |
8-day EMA: | 44.18 | Buy |
20-day EMA: | 38.04 | Buy |
50-day EMA: | 29.95 | Buy |
200-day EMA: | 15.55 | Buy |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Milestone Pharmaceuticals Technical Analysis
Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
24 | 27 | 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | Feb | |||||||||
24 | 27 | 28 | 29 | 30 | 31 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |